Shuying Feng

机构：First Affiliated Hospital of Henan University · ORCID：0000-0002-4771-2908

发表论文 34 篇 · 总被引 1089 次 · h-index 16

代表论文

• Engineered exosome-mediated delivery of functionally active miR-26a and its enhanced suppression effect in HepG2 cells (2018 · International Journal of Nanomedicine · 被引 292)
• A novel composite of collagen-hydroxyapatite/kappa-carrageenan (2016 · Journal of Alloys and Compounds · 被引 93)
• CRISPR/Cas9-induced β-carotene hydroxylase mutation in Dunaliella salina CCAP19/18 (2021 · AMB Express · 被引 61)
• A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles (2023 · Journal of Nanobiotechnology · 被引 48)
• Recent progress in the development of white spot syndrome virus vaccines for protecting shrimp against viral infection (2017 · Archives of Virology · 被引 48)
• Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles (2023 · Journal of Nanobiotechnology · 被引 34)